Literature DB >> 8655991

Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS.

D H Shepp1, M E Match, A B Ashraf, S M Lipson, C Millan, R Pergolizzi.   

Abstract

To determine if cytomegalovirus (CMV) retinitis occurs more frequently in patients infected with certain strains CMV isolates from the blood of 44 patients with advanced human immunodeficiency virus disease were grouped by the DNA sequence or the restriction endonuclease digest pattern of a portion of the glycoprotein B (gB) gene. Forty-two patients (95%) were followed clinically until the development of CMV retinitis or death. Fourteen (78%; 95% confidence interval, 7%-39%) of 26 with isolates belonging to other gB groups developed CMV retinitis (P = .002). Viremia caused by gB group 2 CMV strains is associated with higher risk of CMV retinitis than viremia due to other CMV gB groups. The association of CMV gB gene with retinitis suggests this gene, or one linked to it, is a virulence factor for CMV strains causing infection in AIDS patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8655991     DOI: 10.1093/infdis/174.1.184

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis.

Authors:  Jens-Uwe Vogel; Jürgen Otte; Frank Koch; Hermann Gümbel; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2012-06-06       Impact factor: 3.402

2.  Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes.

Authors:  Jutte J C de Vries; Els Wessels; Anna M H Korver; Annemiek A van der Eijk; Lisette G Rusman; Aloys C M Kroes; Ann C T M Vossen
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

3.  Comparative sequence analysis of US28 gene of human cytomegalovirus strains isolated from HIV-positive patients.

Authors:  Anne Goffard; Elyanne Gault; Flore Rozenberg; Nicole Moret; Didier Hober; Paul Dény
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

4.  Drug-resistant herpesviruses: should we look for them?

Authors:  G Boivin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

5.  High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination.

Authors:  Steven Sijmons; Kim Thys; Mirabeau Mbong Ngwese; Ellen Van Damme; Jan Dvorak; Marnix Van Loock; Guangdi Li; Ruth Tachezy; Laurent Busson; Jeroen Aerssens; Marc Van Ranst; Piet Maes
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

6.  Clinical features of newly diagnosed cytomegalovirus retinitis in northern Thailand.

Authors:  Somsanguan Ausayakhun; Jeremy D Keenan; Sakarin Ausayakhun; Choeng Jirawison; Claire M Khouri; Alison H Skalet; David Heiden; Gary N Holland; Todd P Margolis
Journal:  Am J Ophthalmol       Date:  2012-01-20       Impact factor: 5.258

7.  Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease.

Authors:  P C Woo; C Y Lo; S K Lo; H Siau; J S Peiris; S S Wong; W K Luk; T M Chan; W W Lim; K Y Yuen
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

8.  Role of retinal vascular endothelial cells in development of CMV retinitis.

Authors:  N A Rao; J Zhang; S Ishimoto
Journal:  Trans Am Ophthalmol Soc       Date:  1998

9.  Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR.

Authors:  David Tarragó; Carmen Quereda; Antonio Tenorio
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Strain-specific neutralization of human cytomegalovirus isolates by human sera.

Authors:  M Klein; K Schoppel; N Amvrossiadis; M Mach
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.